Mark J. Alles

2014

In 2014, Mark J. Alles earned a total compensation of $8M as President and Chief Operating Officer at Celgene, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$4,278,167
Option Awards$2,077,620
Salary$767,917
Stock Awards$901,257
Other$21,272
Total$8,046,233

Alles received $4.3M in non-equity incentive plan, accounting for 53% of the total pay in 2014.

Alles also received $2.1M in option awards, $767.9K in salary, $901.3K in stock awards and $21.3K in other compensation.

Rankings

In 2014, Mark J. Alles' compensation ranked 762nd out of 13,032 executives tracked by ExecPay. In other words, Alles earned more than 94.2% of executives.

ClassificationRankingPercentile
All
762
out of 13,032
94th
Division
Manufacturing
278
out of 4,967
94th
Major group
Chemicals And Allied Products
90
out of 1,690
95th
Industry group
Drugs
71
out of 1,369
95th
Industry
Pharmaceutical Preparations
65
out of 1,042
94th
Source: SEC filing on April 28, 2016.

Alles' colleagues

We found six more compensation records of executives who worked with Mark J. Alles at Celgene in 2014.

2014

Robert Hugin

Celgene

Chief Executive Officer

2014

Peter Kellogg

Celgene

Chief Financial Officer

2014

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2014

Thomas Daniel

Celgene

Chairman

2014

Perry Karsen

Celgene

Chief Executive Officer

2014

Scott Smith

Celgene

President, Immunology & Inflammation

You may also like